×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
STRO – sutro biopharma, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
STRO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
3/13
09:01 am
stro
Sutro Biopharma: ADC Developer With Poor Track Record Aims For Positive 2026 [Seeking Alpha]
Medium
Report
Sutro Biopharma: ADC Developer With Poor Track Record Aims For Positive 2026 [Seeking Alpha]
3/3
08:23 am
stro
Kivu Bioscience Appoints Brunilda Shtylla as Chief Business Officer [Yahoo! Finance]
Low
Report
Kivu Bioscience Appoints Brunilda Shtylla as Chief Business Officer [Yahoo! Finance]
2/25
08:48 am
stro
Sutro Biopharma to Participate in Upcoming Investor Conferences [Yahoo! Finance]
Medium
Report
Sutro Biopharma to Participate in Upcoming Investor Conferences [Yahoo! Finance]
2/25
08:30 am
stro
Sutro Biopharma to Participate in Upcoming Investor Conferences
High
Report
Sutro Biopharma to Participate in Upcoming Investor Conferences
2/23
08:30 am
stro
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
Medium
Report
Sutro Biopharma Announces Participation at the 16th World ADC London Summit
2/11
09:02 am
stro
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains? [Yahoo! Finance]
Medium
Report
Sutro Biopharma (STRO) Surges 11.9%: Is This an Indication of Further Gains? [Yahoo! Finance]
2/10
07:00 am
stro
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
High
Report
Sutro Biopharma Announces Pricing of $110.0 million Underwritten Offering
2/10
06:03 am
stro
Sutro Biopharma, Inc. (NASDAQ:STRO) has caught the attention of institutional investors who hold a sizeable 41% stake [Yahoo! Finance]
High
Report
Sutro Biopharma, Inc. (NASDAQ:STRO) has caught the attention of institutional investors who hold a sizeable 41% stake [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
3/6
04:25 pm
stro
Form 4 SUTRO BIOPHARMA, INC. For: Mar 04 Filed by: Pauling David
Low
Report
Form 4 SUTRO BIOPHARMA, INC. For: Mar 04 Filed by: Pauling David
3/6
04:21 pm
stro
Form 4 SUTRO BIOPHARMA, INC. For: Mar 04 Filed by: Chung Jane
Low
Report
Form 4 SUTRO BIOPHARMA, INC. For: Mar 04 Filed by: Chung Jane
3/3
07:00 pm
stro
Form 4 SUTRO BIOPHARMA, INC. For: Mar 01 Filed by: Pauling David
Medium
Report
Form 4 SUTRO BIOPHARMA, INC. For: Mar 01 Filed by: Pauling David
3/3
06:57 pm
stro
Form 4 SUTRO BIOPHARMA, INC. For: Mar 01 Filed by: Gerber Hans-Peter
Medium
Report
Form 4 SUTRO BIOPHARMA, INC. For: Mar 01 Filed by: Gerber Hans-Peter
3/3
06:52 pm
stro
Form 4 SUTRO BIOPHARMA, INC. For: Mar 02 Filed by: Chow Gregory K.
Medium
Report
Form 4 SUTRO BIOPHARMA, INC. For: Mar 02 Filed by: Chow Gregory K.
3/3
06:49 pm
stro
Form 4 SUTRO BIOPHARMA, INC. For: Mar 01 Filed by: Chung Jane
Medium
Report
Form 4 SUTRO BIOPHARMA, INC. For: Mar 01 Filed by: Chung Jane
2/18
07:49 pm
stro
Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P
High
Report
Form SCHEDULE 13G SUTRO BIOPHARMA, INC. Filed by: BIOTECHNOLOGY VALUE FUND L P
2/13
04:50 pm
stro
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Low
Report
Form SCHEDULE 13G/A SUTRO BIOPHARMA, INC. Filed by: SUVRETTA CAPITAL MANAGEMENT, LLC
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
3/24
Sutro Biopharma Inc (NASDAQ: STRO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating.
17.6%
3/16 Form S-8 SUTRO BIOPHARMA, INC. 17.4%
3/19 Sutro Biopharma Inc (NASDAQ: STRO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.00 price target on the stock. 16.8%
1/31 Form 4 SUTRO BIOPHARMA, INC. For: Jan 29 Filed by: ALBINI EDWARD C 15.5%
10/21 Sutro Biopharma Inc (NASDAQ: STRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock. 9.8%
9/5 Sutro Biopharma Inc (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $16.00 price target on the stock. 7.7%
4/20 Sutro Biopharma to Host Conference Call on April 27, 2020, to Provide Clinical Update on its STRO-002 Antibody-Drug Conjugate 7.4%
6/18 Sutro Biopharma to Present at the JMP Securities Life Sciences Conference 6.9%
3/4 Sutro Biopharma to Present Innovative Cancer Therapy Approach Using Precise Tumor Targeted Immunostimulants at World ADC London 6.2%
10/4 Form S-3 SUTRO BIOPHARMA, INC. 5.9%
3/16 Form S-8 SUTRO BIOPHARMA, INC. 17.4%
3/19 Sutro Biopharma Inc (NASDAQ: STRO) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $8.00 price target on the stock. 16.8%
1/31 Form 4 SUTRO BIOPHARMA, INC. For: Jan 29 Filed by: ALBINI EDWARD C 15.5%
10/21 Sutro Biopharma Inc (NASDAQ: STRO) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $18.00 price target on the stock. 9.8%
9/5 Sutro Biopharma Inc (NASDAQ: STRO) had its "market outperform" rating re-affirmed by analysts at JMP Securities. They now have a $16.00 price target on the stock. 7.7%
4/20 Sutro Biopharma to Host Conference Call on April 27, 2020, to Provide Clinical Update on its STRO-002 Antibody-Drug Conjugate 7.4%
6/18 Sutro Biopharma to Present at the JMP Securities Life Sciences Conference 6.9%
3/4 Sutro Biopharma to Present Innovative Cancer Therapy Approach Using Precise Tumor Targeted Immunostimulants at World ADC London 6.2%
10/4 Form S-3 SUTRO BIOPHARMA, INC. 5.9%
TOP News Decliners
3/16
Sutro Biopharma Inc (NASDAQ: STRO) was downgraded by analysts at ValuEngine from a "buy" rating to a "hold" rating.
-39.3%
4/24 Form DEF 14A SUTRO BIOPHARMA, INC. For: Jun 05 -16.5%
10/7 Sutro Bio up 22% after mixed shelf filing [Seeking Alpha] -12.6%
3/10 Sutro Biopharma Inc (NASDAQ: STRO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -10.4%
2/27 Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference -8.3%
5/14 Q1/2019 3/31/2019 EPS -0.620 ZacksConsensus N/A ActVsEst N/A - N/A -7.7%
8/14 Q2/2019 6/30/2019 EPS -0.600 ZacksConsensus N/A ActVsEst N/A - N/A -7.0%
9/30 Form 4 SUTRO BIOPHARMA, INC. For: Sep 26 Filed by: ALBINI EDWARD C -4.4%
3/12 Sutro Biopharma Announces Extension of First Cytokine Derivative Research Program Under Collaboration with Merck -3.9%
1/8 Sutro Biopharma Appoints James Panek to Board of Directors -3.5%
4/24 Form DEF 14A SUTRO BIOPHARMA, INC. For: Jun 05 -16.5%
10/7 Sutro Bio up 22% after mixed shelf filing [Seeking Alpha] -12.6%
3/10 Sutro Biopharma Inc (NASDAQ: STRO) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -10.4%
2/27 Sutro Biopharma to Present at the Cowen and Company 40th Annual Health Care Conference -8.3%
5/14 Q1/2019 3/31/2019 EPS -0.620 ZacksConsensus N/A ActVsEst N/A - N/A -7.7%
8/14 Q2/2019 6/30/2019 EPS -0.600 ZacksConsensus N/A ActVsEst N/A - N/A -7.0%
9/30 Form 4 SUTRO BIOPHARMA, INC. For: Sep 26 Filed by: ALBINI EDWARD C -4.4%
3/12 Sutro Biopharma Announces Extension of First Cytokine Derivative Research Program Under Collaboration with Merck -3.9%
1/8 Sutro Biopharma Appoints James Panek to Board of Directors -3.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: